A B S T R A C T Myeloid differentiation in vitro is characterized by the sequential appearance of-morphological, functional, and biochemical markers of maturation. We examined the effect of agents that increased the intracellular concentration of adenosine 3'5'-cyclic monophosphate on the expression of these markers by human promyelocytic leukemia cells (HL60). Cells treated with 500 ,M N6,02-dibutyryl adenosine 3'5'-cyclic monophosphate expressed formyl peptide and complement receptors, reduced nitroblue tetrazolium, adhered to substrate, demonstrated chemotaxis and stimulated lysosomal enzyme release, rapidly ceased proliferation, and assumed the morphology of myelocytes and metamyelocytes. Prostaglandin E2 (100 nM) and theophyllin (500 AM) induced similar functional changes but the cells did not mature beyond the myelocyte stage. Cholera toxin (1 or 50 nM) induced formyl-peptide receptor expression and adherence, but the cells did not reduce nitroblue tetrazolium, continued to proliferate, and were unchanged morphologically. Formyl-peptide receptor expression was the earliest marker of these modified programs of maturation. The receptor appeared within 2 h after treatment and increased linearly for 72 h. Receptor expression was dependent on new protein synthesis. At 48 h, Scatchard analysis demonstrated 2.4 X 105 receptors/ cell with a KD of 1.3 nM.
A B S T R A C T Myeloid differentiation in vitro is characterized by the sequential appearance of-morphological, functional, and biochemical markers of maturation. We examined the effect of agents that increased the intracellular concentration of adenosine 3'5'-cyclic monophosphate on the expression of these markers by human promyelocytic leukemia cells (HL60). Cells treated with 500 ,M N6,02-dibutyryl adenosine 3'5'-cyclic monophosphate expressed formyl peptide and complement receptors, reduced nitroblue tetrazolium, adhered to substrate, demonstrated chemotaxis and stimulated lysosomal enzyme release, rapidly ceased proliferation, and assumed the morphology of myelocytes and metamyelocytes. Prostaglandin E2 (100 nM) and theophyllin (500 AM) induced similar functional changes but the cells did not mature beyond the myelocyte stage. Cholera toxin (1 or 50 nM) induced formyl-peptide receptor expression and adherence, but the cells did not reduce nitroblue tetrazolium, continued to proliferate, and were unchanged morphologically. Formyl-peptide receptor expression was the earliest marker of these modified programs of maturation. The receptor appeared within 2 In contrast to induction of HL60 differentiation by dimethyl sulfoxide, retinoic acid, or phorbol myristate acetate, the developmental programs initiated by agents that raised intracellular adenosine 3'5'-cyclic monophosphate shared several unique features: (a) plasma membrane maturation was dissociated from morphological maturation; (b) no latent period was evident following induction-the earliest membrane INTRODUCTION The human leukemic cell line (HL60), derived from a patient with acute promyelocytic leukemia, has been maintained in continuous culture for >5 yr (1) . These cells, which grow as myeloblasts and promyelocytes, can be induced to differentiate into mature myeloid forms with a variety of agents. For example, after 3-7 d of continuous exposure to dimethyl sulfoxide (DMSO),' HL60 cells exhibit a reduced nuclear-cytoplasmic ratio, loss of nucleoli, decreased azurophilic granules, and assume the morphologic characteristics of metamyelocytes (2) . Biochemically, these cells reduce nitroblue tetrazolium (NBT), generate superoxide, and express membrane receptors for complement and chemotactic formyl peptide (3) (4) (5) . Functionally, the differentiated cells are similar to neutrophils, as they demonstrate chemotaxis, chemokinesis, adherence, phagocytosis, and stimulated enzyme release (3) (4) (5) (6) .
The HL60 system, thus, provides a model for the study of plasma membrane development and receptor expression during myeloid differentiation. Unfortunately, DMSO-induced membrane maturation is often variable and incomplete (5) . We therefore sought alternative inducers that would reproducibly cause membrane maturation and chemotactic peptide receptor expression in all of the treated cells. In addition to defining a new class of inducers, use of such agents rray help to define the molecular mechanisms of cell differentiation.
A number of agents that increase intracellular cyclic AMP (cAMP) by either stimulating adenylate cyclase, inhibiting cyclic nucleotide phosphodiesterase, or being a cell-permeant analogue of cAMP, inhibit proliferation of hematopoetic cells as assessed in a soft-agar cloning assay (7) (8) (9) (10) . Such treatment can also induce irreversible morphological differentiation in certain malignant cell lines (11, 12) . In this study, we show that N6,02 dibutyryl adenosine 3'5' cyclic monophosphate (dbcAMP) and other related agents induce a modified program of myeloid differentiation in the HL60 cell line. After exposure to dbcAMP, the chemotactic receptor is rapidly synthesized and the cells are able to reduce NBT, release lysosomal enzymes, demonstrate chemotaxis, and adhere to substrate. Agents that presumably increase intracellular cAMP induced HL60 cells to undergo a program of plasma membrane differentiation, without concomitant morphologic maturation. Radioligand and fluorescent binding assay. N-FormylNle-Leu-Phe-Nle ['25I]Tyr-Lys (formyl-'251-peptide) was prepared by the chloramine-T method (13) . The specific activity of the iodinated peptide varied from 200 to 600 cpm/fmol. The tetramethyl-rhodamine-labeled formyl peptide (fluorescent formyl peptide) was prepared and used in fluorescent studies (14) .
METHODS
Cells were harvested by centrifugation and washed twice with assay buffer (15 mM sodium phosphate/123 mM sodium chloride/0.1% bovine albumin pH 6.75). The formyl 1251-peptide binding assay was a modification of the method described elsewhere (5, 14) . Briefly, 360,000 cells and formyl 1251-peptide (500 fmol) in 200 ul assay buffer were incubated at 22°C for 30 min or 4°C for 3 h. Binding was terminated by addition of 2 ml of 4°C incubation buffer and rapid filtration through a W-hatman GF/C filter (Whatman Inc., Chemical Separation Div., Clifton, NJ). The filters were washed with 10 ml of 4°C phosphate-buffered saline (PBS) and counted for 125I. Nonsaturable binding was determined by an identical method except for the addition of 125 nM unlabeled formyl peptide during the binding incubation. Specific binding refers to total binding minus nonsaturable binding. Data points were measured in duplicate or triplicate with a standard error consistently < ±10%.
Marker studies. Cytocentrifuged samples were evaluated with Wright's stain, and morphologic maturity was determined by multiple factors including decrease of azurophilic granules, decreased nuclear-cytoplasmic ratio, loss of nucleoli, increased nuclear density, and identations of nucleus. a-Naphthol AS-D acetate (nonspecific) esterase was assayed as described elsewhere (15) . Adherence was determined on a hemocytometer glass cover slip after incubation at 37°C for 15 min.
Formyl peptide-stimulated fl-glucuronidase release was determined by a modification of established methods (16, 17) . Briefly, 3 X 106 cells were suspended for 10 min in 250
Al buffer (PBS containing 0.5 mM MgC92, 0.5 mM CaCl2, 0.2% bovine serum albumin, and cytochalasin B 10 ,g/rml).
Each concentration of formyl peptide was added, and after 5 min at 37°C, cells were centrifuged at 500 g for 15 min. Control cells were lysed with Triton X-100 and teflon-glass homogenized. Cells and lysates were centrifuged at 39,000 g for 20 min at 4°C. 100 gl of supernatant of the formyl peptide-stimulated and control lysed cells were incubated with 900,l buffer (50 mM sodium acetate, 0.1% Triton X-100, 1 mM p-nitrophenyl-f-D-glucuronide, pH 5.00) at 37°C for 12 h. The reaction was terminated by the addition of 2.0 ml of 0.1 M sodium hydroxide. The 3-glucuronidase assay measured the formation of p-nitrophenol from p-nitrophenyl fl-D-glucuronide at 410 nM and was expressed as percent release of total cellular enzyme.
For NBT reduction studies, 2 X 106 cells in 1 ml RPMI 1640 with 15% fetal bovine serum were incubated at 37°C for 20 min with 1 ml 0.2% NBT solution in the presence of 200 ng of freshly diluted PMA or 50 nM N-formyl-Nle-LeuPhe-Nle-Tyr-Lys. The percentage of cells containing membrane deposits of reduced black formazan on a cytospin preparation was determined for 200 cells and repeated in triplicate for each score. The chemotactic response was estimated by the method of Boyden (5) as reported previously using 5-Am filters.
Complement receptors on HL60 cells were determined by rosetting of complement-coated erythrocytes (EAC). Accordingly, 0.5 ml of a 2% human erythrocyte suspension was sensitized with 0.5 ml of a 1:100 dilution of high titer cold agglutinin serum and 0.5 ml of fresh plasma. The erythrocytes, serum, and plasma were incubated for 10 (2-4, 18, 19) . On striking difference, however, was the early appearance of the formyl-peptide receptor. In response to 500 AM dbcAMP, an increase in formyl '251-peptide binding was seen within 2 h and continued to increase linearly for 72 h, finally reaching a plateau at >300 fmol formyl peptide bound per 106 cells. With DMSO induction, receptor expression was not seen until day 3 and plateaued at _100-fmol/106 cells (Fig. 2) . The extent of formyl-peptide receptor expression showed a reproducible dose-dependent relationship with increasing concentrations of dbcAMP (Fig. 3) . Below 100 ,uM dbcAMP, neither an increase in chemotactic receptor nor morphologic changes were evident. The maximum receptor expression occurred in response to 500 ,M-1 mM dbcAMP.
By 24 h of exposure of 500 AM dbcAMP, >95% of the HL60 cells demonstrated saturable receptor-mediated internalization of the fluorescent formyl peptide (data not shown). This cellular homogeneity was in contrast to DMSO-treated cells, which showed fluorescent binding and internalization in a maximum of 30% of the cells even after prolonged exposure to DMSO (5). Fluorescent peptide uptake by peripheral neutrophils was qualitatively similar, but less intense than the uptake by dbcAMP-treated cells (14) . The rates of internalization of the fluorescent peptide by dbcAMP-treated cells, peripheral neutrophils, and the subpopulation of untreated HL60 cells, which spontaneously differentiated (5), appeared identical.
The standard receptor assay at 22°C measures both membrane surface binding and internalization of the radioligand (13, 14) . Cellular uptake of formyl 1251_ peptide was rapid at 22°C with a maximum value at 30 min. At 4°C, bound formyl 1251-peptide remained on the cell surface of dbcAMP-treated cells and equilibrium was not achieved until 3 h of exposure. At both temperatures, binding to dbcAMP-treated cells was saturable with a plateau above 2.5 nM formyl peptide. After 48 h of HL60 exposure to 500 MM dbcAMP, Scatchard analysis of binding at 4°C revealed a receptor density of 240,000 receptors/cell with a Kd of 1.3 nM. This binding affinity was similar to that of peripheral neutrophils, but the receptor density was approximately fourfold greater in the induced HL60 cells, although the cells remained morphologically immature at 48 h (Fig. 1) . Scatchard analysis of binding to uninduced cells at 4°C was not possible because binding was too low to be reliably measured.
Formyl peptide-stimulated,-glucuronidase release, chemotaxis, and NBT reduction were used as measures of the physiologic function of the newly expressed forCyclic Nucleotide-induced Maturation of Human Leukemia Cells 955 (Fig. 4) .
Effect of cyclic nucleotides and prostaglandins on chemotactic receptor expression. Dibutyryl cAMP may have induced chemotactic receptor synthesis, inhibited cellular proliferation, and induced morphologic maturation by mechanisms unrelated to cyclic nucleotides. To explore these alternative possibilities, other nucleotide analogues, prostaglandins, and inhibitors of cyclic nucleotide phosphodiesterase were tested and compared with the results of dbcAMP treatment (Table II) . Those agents believed to raise intracellular levels of cAMP consistently induced early receptor expression, early inhibition of proliferation, but minimal morphological maturation.
Prostaglandins increase cAMP by stimulating adenylate cyclase. With 100 nM PGE1 or PGE2, early chemotactic receptor expression occurred within the first 24 h of treatment, similar to the standard dbcAMP treatment. These agents inhibited cellular proliferation, increased membrane deposits of NBT, and stimulated glass adherence. The treatment did not induce obvious granulocytic maturation, but the majority of cells were not morphologically identical to untreated promyelocytes. The most obvious change was loss of azurophilic granules and apparent increase in cytoplasmic volume (Fig. 1) . Theophyllin (500,uM) alone did not induce any of these cellular changes. However, early chemotactic receptor expression in response to suboptimal doses of PGE2 (10 nM) was increased by simultaneous exposure to theophyllin (500 ,M). In other experiments, theophyllin acted synergistically with DMSO; the two agents together induced early receptor expression. Cholera toxin, another agent that stimulates adenylate cyclase, induced an early increase in receptor binding but failed to decrease proliferation or induce morphologic change. Isoproterenol, a potent (3-agonist, neither influenced morphologic appearance nor chemotactic receptor expression.
Unmodified cyclic AMP, which does not traverse the cell membrane, was ineffective in inducing any cel- 4 or 24 h, then washed and resuspended in new media without inducer. These cells were compared with cells continuously exposed to the inducers. Continuous exposure to dbcAMP was required for the linear increase in formyl '25I-peptide binding (Fig. 5a ) and for the development of morphologic maturation and NBT reduction (Fig. 5b) . When dbcAMP was removed after 4 h, there was no increase in receptor expression nor morphologic change. Following washout of dbcAMP at 24 h, formyl-_251-peptide binding decreased toward base line (Fig. Sa) and the cells gradually resumed proliferation (Fig. Sb) . These cells did not reduce NBT or show evidence of morphologic maturation (Fig. Sb) . The increased expression of chemotactic receptor at 24 h was quite homogeneous as 95% of cells bound and internalized the fluorescent formyl peptide. However the majority of these cells must not have been committed to receptor expression because following removal of dbcAMP at 24 h, only 16% remained receptor positive at 72 h. Cell density increased from 1.7 X 106 cells/ml to 2.3 X 106 to typical mature granulocytic features, but 70% of the cells were able to reduce NBT by day 5 (Fig. 6b) . 4 h of exposure to PGE2 did not induce receptor expression nor decrease cellular proliferation. free of PGE2 after 24 h exhibited a stable plateau in peptide binding. Over this interval, a decrease in the proportion of cells positive for fluorescent-peptide binding was evident (Fig. 6a) , although cell density did not change (Fig. 6b) (20) . Incubation of HL60 cells with 1 nM cholera toxin induced an increase in binding of both formyl 125I-peptide and fluorescent peptide (Fig. 7) . A similar increase in receptor expression was seen when cells were treated for only 4 or 24 h, consistent with the irreversible nature of adenylate cyclase activation by cholera toxin. Binding of formyl '251-peptide slowly increased during the 5 d of culture, but the proportion of cells positive for the fluorescent peptide gradually decreased. At 1 or 50 nM cholera toxin, neither changes in the rate of cell proliferation, NBT reduction, nor morphology could be detected.
DISCUSSION
The study of myeloid differentiation has become experimentally accessible since the establishment of the HL60 cell line by Collins et al. (1) . Many of the agents, including DMSO, dimethyl formamide, butyric acid, and acetamide derivatives, which induce differentiation of other malignant cell lines, also induce granulocytic maturation of the HL60 cell line (18) . Retinoids induce granulocytic maturation at concentrations --5 logs lower than the concentrations required for other inducers (19) . All these agents induce a similar developmental program of differentiation as an orderly sequence of myeloid markers appears. The phorbol diesters uniquely induce differentiation of HL60 cells into macrophages, without production of granulocyte elements (21) .
Although a unifying mechanism underlying induction of differentiation has not been established, evidence from other cell lines suggests that cyclic nucleotides may be involved (11, 12, 22, 23) . Synchronized mouse erythroleukemia cells demonstrate a five-to sixfold increase in intracellular cAMP during mid-S phase after exposure to chemically diverse inducers (24) . Elevation of intracellular cAMP in mouse and human neuroblastoma lines is one of the presumed mechanisms for inducing morphologic differentiation to mature neurons (25) (26) (27) (28) and increasing neurotransmitter-related enzyme synthesis (29 ceptor is detectable within 2 h; (b) a dissociation occurs between differentiation of the plasma membrane and morphologic maturation; (c) a prompt cessation of cellular proliferation accompanies early membrane changes; and (d) commitment to terminal differentiation has not occurred in a majority of the cells at a time when >95% of the cells have expressed a differentiation marker, the formyl-peptide receptor. Cyclic AMP analogues and prostaglandins had been tested previously in leukemic lines, using a clonogenic softagar assay system, but these compounds had not led to obvious morphologic change and were not studied further (10) . Our study confirms that terminal myeloid differentiation is not evident after treatment with such agents. However, several markers of plasma membrane maturation, including the chemotactic and complement receptors, NBT dye reduction, chemotaxis, and cell adherence to glass, are expressed after treat- (5, 6) . DMSO-induced receptor expression, however, is variable and occurs in only 20-40% of cells. Recently, Brandt et al. (30) described a twofold increase in this receptor when DMSO and dexamethasone were used concomitantly for induction, but whether this treatment recruited a higher percentage of receptor-positive cells is unknown. Table II demonstrates that treatment with various agents induced chemotactic receptor expression as either an early or late event. Cell-permeant cAMP analogues and stimulators of adenylate cyclase, with or without cyclic nucleotide phosphodiesterase inhibitors, all produced early expression of the chemotactic receptor. In contrast to other inducers, these agents reproducibly induced receptor expression in at least 95% of cells, to a level three to five times greater than that seen with other classes of inducers. The induced receptor displays binding properties similar to the receptor on mature neutrophils and is coupled to the mechanisms for lysosomal enzyme release, chemotaxis, NBT reduction, and peptide endocytosis. Receptor expression in response to these agents, therefore, provides an ideal in vitro system for the study of the formyl-peptide receptor.
Many experiments in our study make use of dbcAMP, a cell-permeant cyclic nucleotide. However, this is not an ideal model compound because intracellular hydrolysis of dbcAMP to butyrate and cAMP renders interpretation difficult. Elevated intracellular butyrate may also be responsible for the morphologic change and the increased receptor expression seen late in the culture with dbcGMP and dbcAMP treatment. Prostaglandins of the E series and cholera toxin increase intracellular cAMP without the complicating increase in butyrate. PGE2 clearly dissociated receptor expression, NBT (23, 25, 31) . Unmodified nucleotide does not enter the cell but is readily dephosphorylated to adenosine, which can freely enter the cell. Following intracellular rephosphorylation, the elevated concentration of 5'AMP is a potent inhibitor of phosphoribosyl-pyrophosphate synthetase, thereby blocking de novo pyrimidine synthesis and causing pyrimidine nucleoside starvation (32) . Rescue of cells from this inhibitory effect of 5'AMP has been previously demonstrated by the addition of cytidine and uridine to the cultured cells (23) . In our studies, the cell-permeant nucleoside, adenosine, neither stimulated differentiation nor induced receptor synthesis, rendering pyrimidine starvation an unlikely mechanism.
Previous studies with in vitro bone marrow culture have suggested that cAMP and prostaglandins may have a regulatory role in hematopoiesis (9) . Colonyforming units of granulocyte precursors (CFU-GM) proliferation is under the dual control of macrophagederived colony-stimulating factor (CSF) and prostaglandin of the E series (7-10, 33, 34) . When soft-agar bone marrow culture was performed in the absence of adherent cells believed to produce CSF, cAMP and PGE were shown to be inhibitors of CFU-GM proliferation (9) . HL60 proliferation may be influenced by autostimulatory growth factors similar to CSF (35) . In preliminary studies, we have used acridine orange and the fluorescence-activated cell sorter to assess cellular DNA -content. These studies demonstrate that the inhibition of proliferation observed in soft-agar culture is also evident in suspension culture within the first 24 h after treatment with agents that increase intracellular cAMP. This is in contrast to the 3-4-d delay in inhibition of exponential growth following treatment with DMSO and retinoids.
In addition to studying plasma membrane maturation as a function of increased intracellular cAMP, the present study was designed to study cAMP-mediated commitment to myeloid differentiation. Commitment is defined operationally as the capacity of cells that have been exposed to inducer to express differentiated characteristics in the absence of inducer. Exposure to DMSO for 12 h is the minimal requirement to promote a stochastic commitment to terminal myeloid differentiation in a fraction of HL60 cells (36) . However, a latent period of 72 h occurs between induction by DMSO and the appearance of the earliest functions (2, 5, 36) . In the mouse erythroleukemia system, a recent study has shown commitment to be a multistep process involving inducers and inhibitors of induction (37) . Our studies demonstrate that increased intracellular cAMP abolished the latent period for the expression of an inducible membrane receptor in myeloid differentiation. However, commitment to membrane differentiation was delayed and incomplete. For instance, after 24 h of exposure to dbcAMP, >95% of the cells expressed the chemotactic receptor, but following wash-out of this inducer, 80% of these cells ceased 962 receptor expression (Fig. 5) . Overgrowth of the small population of receptor-negative cells cannot explain this dramatic decrease in receptor-positive cells because cell density increased by only 35%. When washout of dbcAMP or PGE2 was performed after 48 h of exposure, commitment to receptor expression, NBT reduction, and adherence was evident in >70% of cells, indicating that commitment had occured between 24 and 48 h. Cholera toxin, an irreversible activator of adenylate cyclase, induced the chemotactic receptor, but did not induce the membrane enzyme system responsible for NBT reduction. Receptor expression was slowed, but not abolished after washout of cholera toxin.
Our study implies a role for cAMP in the induction of plasma membrane maturation. Experiments of Gazitt et al., (24) (38, 39) . Subgroups of human myeloid leukemia may respond to in vivo modulation with such agents.
